Amgen (AMGN) will invest an initial $200 million this year in its new technology center in southern India, Reuters reported Monday, citing Chief Executive Robert Bradway.
The US drugmaker has also planned "significant" investments for future years as part of its plan to expand its presence in India, according to the report.
By the end of the year, the site in Hyderabad city is expected to have a workforce of roughly 2,000, Reuters reported, citing Som Chattopadhyay, national executive for India at Amgen.
Amgen did not immediately respond to MT Newswires' request for comment.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。